Jung Gundram

Title: Jung Gundram: Innovator in Fusion Protein Technology

Introduction

Jung Gundram is a notable inventor based in Rottenburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His innovative work has implications for therapeutic applications, showcasing the potential of his inventions in medical science.

Latest Patents

Jung Gundram holds a patent for "Fusion proteins comprising a binding protein and an interleukin-15 polypeptide having a reduced affinity for IL15Ra and therapeutic uses thereof." This invention relates to fusion proteins that combine a binding protein with an IL-15 polypeptide. The patent outlines the pharmaceutical compositions that include these fusion proteins and describes methods for their production. He has 1 patent to his name, reflecting his focused contributions to this specialized area.

Career Highlights

Throughout his career, Jung Gundram has worked with prestigious institutions, including the German Cancer Research Center (Deutsches Krebsforschungszentrum) and Eberhard Karls University of Tübingen. His roles in these organizations have allowed him to advance his research and collaborate with other experts in the field.

Collaborations

Jung Gundram has collaborated with notable colleagues, including Cornelia Lindner and Berit Lochmann. These partnerships have enriched his research endeavors and contributed to the development of innovative solutions in biotechnology.

Conclusion

Jung Gundram's work in fusion protein technology exemplifies the intersection of innovation and therapeutic application. His contributions are paving the way for advancements in medical treatments, highlighting the importance of research in biotechnology.